本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kronos Bio, Inc.

0.7790
-0.0210-2.62%
盤後0.77900.00000.00%16:00 EDT
成交量:29.50萬
成交額:23.18萬
市值:4,749.50萬
市盈率:-0.54
高:0.8250
開:0.7800
低:0.7710
收:0.8000
資料載入中...

公司資料

公司名字:
Kronos Bio, Inc.
交易所:
NASDAQ
成立時間:
2017
員工人數:
10
公司地址:
1300 South El Camino Real,Suite 400,San Mateo,California,United States
郵編:
94402
電話:
傳真:
- -
簡介:
Kronos Bio, Inc.於2017年6月2日根據特拉華州法律成立。該公司是一家臨床階段的生物製藥公司,致力於發現和開發新的癌症療法,旨在通過針對失調轉錄的精確藥物策略來改變患者的預后。

董事

名稱
職位
Arie Belldegrun
Chairman of the Board of Director
Norbert Bischofberger
Director, President and Chief Executive Officer
David Tanen
Director
Elena Ridloff
Director
Jakob Loven
Director
John C. Martin
Director
Joshua Kazam
Director
Otello Stampacchia
Director
Rebecka Belldegrun
Director

股東

名稱
職位
Norbert Bischofberger
Director, President and Chief Executive Officer
Barbara Kosacz
Chief Operating Officer and General Counsel
Yasir Al Wakeel
Chief Financial Officer and Head of Corporate Development
Christopher Dinsmore
Chief Scientific Officer
Jorge DiMartino
Chief Medical Officer and Executive Vice President, Clinical Development